nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP3A4—Esomeprazole—Barrett's esophagus	0.187	0.397	CbGbCtD
Cevimeline—CYP2D6—Omeprazole—Barrett's esophagus	0.173	0.368	CbGbCtD
Cevimeline—CYP3A4—Omeprazole—Barrett's esophagus	0.11	0.234	CbGbCtD
Cevimeline—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—ATP4A—Barrett's esophagus	0.00715	0.242	CbGpPWpGaD
Cevimeline—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—GAST—Barrett's esophagus	0.00571	0.194	CbGpPWpGaD
Cevimeline—FMO1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.0027	0.0917	CbGpPWpGaD
Cevimeline—FMO1—Biological oxidations—CYP26A1—Barrett's esophagus	0.00144	0.0487	CbGpPWpGaD
Cevimeline—FMO1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00142	0.0481	CbGpPWpGaD
Cevimeline—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.00137	0.00273	CcSEcCtD
Cevimeline—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.00137	0.00273	CcSEcCtD
Cevimeline—Cystitis—Esomeprazole—Barrett's esophagus	0.00135	0.0027	CcSEcCtD
Cevimeline—Cystitis—Omeprazole—Barrett's esophagus	0.00135	0.0027	CcSEcCtD
Cevimeline—Candida infection—Esomeprazole—Barrett's esophagus	0.00133	0.00266	CcSEcCtD
Cevimeline—Candida infection—Omeprazole—Barrett's esophagus	0.00133	0.00266	CcSEcCtD
Cevimeline—Vaginal infection—Omeprazole—Barrett's esophagus	0.00132	0.00264	CcSEcCtD
Cevimeline—Vaginal infection—Esomeprazole—Barrett's esophagus	0.00132	0.00264	CcSEcCtD
Cevimeline—Oesophagitis—Esomeprazole—Barrett's esophagus	0.00128	0.00255	CcSEcCtD
Cevimeline—Oesophagitis—Omeprazole—Barrett's esophagus	0.00128	0.00255	CcSEcCtD
Cevimeline—Neoplasm—Esomeprazole—Barrett's esophagus	0.00126	0.00252	CcSEcCtD
Cevimeline—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00126	0.00252	CcSEcCtD
Cevimeline—Bladder pain—Omeprazole—Barrett's esophagus	0.00126	0.00252	CcSEcCtD
Cevimeline—Bladder pain—Esomeprazole—Barrett's esophagus	0.00126	0.00252	CcSEcCtD
Cevimeline—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00126	0.00252	CcSEcCtD
Cevimeline—Neoplasm—Omeprazole—Barrett's esophagus	0.00126	0.00252	CcSEcCtD
Cevimeline—Urine output increased—Omeprazole—Barrett's esophagus	0.00126	0.00252	CcSEcCtD
Cevimeline—Urine output increased—Esomeprazole—Barrett's esophagus	0.00126	0.00252	CcSEcCtD
Cevimeline—Hypertonia—Omeprazole—Barrett's esophagus	0.00123	0.00245	CcSEcCtD
Cevimeline—Hypertonia—Esomeprazole—Barrett's esophagus	0.00123	0.00245	CcSEcCtD
Cevimeline—Abnormal vision—Esomeprazole—Barrett's esophagus	0.00122	0.00243	CcSEcCtD
Cevimeline—Abnormal vision—Omeprazole—Barrett's esophagus	0.00122	0.00243	CcSEcCtD
Cevimeline—Ear pain—Omeprazole—Barrett's esophagus	0.00119	0.00237	CcSEcCtD
Cevimeline—Ear pain—Esomeprazole—Barrett's esophagus	0.00119	0.00237	CcSEcCtD
Cevimeline—Lymphadenopathy—Omeprazole—Barrett's esophagus	0.00119	0.00237	CcSEcCtD
Cevimeline—Lymphadenopathy—Esomeprazole—Barrett's esophagus	0.00119	0.00237	CcSEcCtD
Cevimeline—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00117	0.00233	CcSEcCtD
Cevimeline—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00117	0.00233	CcSEcCtD
Cevimeline—Polyuria—Esomeprazole—Barrett's esophagus	0.00116	0.00231	CcSEcCtD
Cevimeline—Polyuria—Omeprazole—Barrett's esophagus	0.00116	0.00231	CcSEcCtD
Cevimeline—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00114	0.00229	CcSEcCtD
Cevimeline—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00114	0.00229	CcSEcCtD
Cevimeline—Vascular purpura—Esomeprazole—Barrett's esophagus	0.00113	0.00226	CcSEcCtD
Cevimeline—Vascular purpura—Omeprazole—Barrett's esophagus	0.00113	0.00226	CcSEcCtD
Cevimeline—Injury—Esomeprazole—Barrett's esophagus	0.0011	0.0022	CcSEcCtD
Cevimeline—Injury—Omeprazole—Barrett's esophagus	0.0011	0.0022	CcSEcCtD
Cevimeline—Hot flush—Esomeprazole—Barrett's esophagus	0.00108	0.00217	CcSEcCtD
Cevimeline—Hot flush—Omeprazole—Barrett's esophagus	0.00108	0.00217	CcSEcCtD
Cevimeline—Increased appetite—Esomeprazole—Barrett's esophagus	0.00108	0.00216	CcSEcCtD
Cevimeline—Increased appetite—Omeprazole—Barrett's esophagus	0.00108	0.00216	CcSEcCtD
Cevimeline—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00108	0.00215	CcSEcCtD
Cevimeline—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00108	0.00215	CcSEcCtD
Cevimeline—Thirst—Omeprazole—Barrett's esophagus	0.00107	0.00213	CcSEcCtD
Cevimeline—Renal impairment—Esomeprazole—Barrett's esophagus	0.00107	0.00213	CcSEcCtD
Cevimeline—Renal impairment—Omeprazole—Barrett's esophagus	0.00107	0.00213	CcSEcCtD
Cevimeline—Thirst—Esomeprazole—Barrett's esophagus	0.00107	0.00213	CcSEcCtD
Cevimeline—Purpura—Esomeprazole—Barrett's esophagus	0.00105	0.0021	CcSEcCtD
Cevimeline—Purpura—Omeprazole—Barrett's esophagus	0.00105	0.0021	CcSEcCtD
Cevimeline—Arthritis—Omeprazole—Barrett's esophagus	0.00104	0.00208	CcSEcCtD
Cevimeline—Arthritis—Esomeprazole—Barrett's esophagus	0.00104	0.00208	CcSEcCtD
Cevimeline—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00104	0.00208	CcSEcCtD
Cevimeline—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00104	0.00208	CcSEcCtD
Cevimeline—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00102	0.00203	CcSEcCtD
Cevimeline—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00102	0.00203	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00101	0.00203	CcSEcCtD
Cevimeline—Diplopia—Omeprazole—Barrett's esophagus	0.00101	0.00203	CcSEcCtD
Cevimeline—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00101	0.00203	CcSEcCtD
Cevimeline—Pain in extremity—Omeprazole—Barrett's esophagus	0.00101	0.00203	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00101	0.00203	CcSEcCtD
Cevimeline—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00101	0.00203	CcSEcCtD
Cevimeline—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00101	0.00203	CcSEcCtD
Cevimeline—Diplopia—Esomeprazole—Barrett's esophagus	0.00101	0.00203	CcSEcCtD
Cevimeline—Migraine—Esomeprazole—Barrett's esophagus	0.000999	0.00199	CcSEcCtD
Cevimeline—Migraine—Omeprazole—Barrett's esophagus	0.000999	0.00199	CcSEcCtD
Cevimeline—Face oedema—Esomeprazole—Barrett's esophagus	0.00098	0.00196	CcSEcCtD
Cevimeline—Face oedema—Omeprazole—Barrett's esophagus	0.00098	0.00196	CcSEcCtD
Cevimeline—Dry skin—Omeprazole—Barrett's esophagus	0.00093	0.00186	CcSEcCtD
Cevimeline—Dry skin—Esomeprazole—Barrett's esophagus	0.00093	0.00186	CcSEcCtD
Cevimeline—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.000923	0.00184	CcSEcCtD
Cevimeline—Hypokalaemia—Omeprazole—Barrett's esophagus	0.000923	0.00184	CcSEcCtD
Cevimeline—Gastritis—Omeprazole—Barrett's esophagus	0.000898	0.00179	CcSEcCtD
Cevimeline—Gastritis—Esomeprazole—Barrett's esophagus	0.000898	0.00179	CcSEcCtD
Cevimeline—Muscular weakness—Esomeprazole—Barrett's esophagus	0.000895	0.00179	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000895	0.00179	CcSEcCtD
Cevimeline—Muscular weakness—Omeprazole—Barrett's esophagus	0.000895	0.00179	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000895	0.00179	CcSEcCtD
Cevimeline—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00089	0.0302	CbGpPWpGaD
Cevimeline—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000883	0.00176	CcSEcCtD
Cevimeline—Abdominal distension—Omeprazole—Barrett's esophagus	0.000883	0.00176	CcSEcCtD
Cevimeline—Dysphagia—Omeprazole—Barrett's esophagus	0.000877	0.00175	CcSEcCtD
Cevimeline—Dysphagia—Esomeprazole—Barrett's esophagus	0.000877	0.00175	CcSEcCtD
Cevimeline—Asthma—Omeprazole—Barrett's esophagus	0.000877	0.00175	CcSEcCtD
Cevimeline—Asthma—Esomeprazole—Barrett's esophagus	0.000877	0.00175	CcSEcCtD
Cevimeline—Bronchospasm—Esomeprazole—Barrett's esophagus	0.000863	0.00172	CcSEcCtD
Cevimeline—Bronchospasm—Omeprazole—Barrett's esophagus	0.000863	0.00172	CcSEcCtD
Cevimeline—Sweating increased—Omeprazole—Barrett's esophagus	0.000854	0.00171	CcSEcCtD
Cevimeline—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000854	0.00171	CcSEcCtD
Cevimeline—Sweating increased—Esomeprazole—Barrett's esophagus	0.000854	0.00171	CcSEcCtD
Cevimeline—Angina pectoris—Omeprazole—Barrett's esophagus	0.000854	0.00171	CcSEcCtD
Cevimeline—Dysuria—Omeprazole—Barrett's esophagus	0.00082	0.00164	CcSEcCtD
Cevimeline—Dysuria—Esomeprazole—Barrett's esophagus	0.00082	0.00164	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000815	0.00163	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000815	0.00163	CcSEcCtD
Cevimeline—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00081	0.00162	CcSEcCtD
Cevimeline—Pollakiuria—Omeprazole—Barrett's esophagus	0.00081	0.00162	CcSEcCtD
Cevimeline—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.000808	0.00161	CcSEcCtD
Cevimeline—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.000808	0.00161	CcSEcCtD
Cevimeline—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.0008	0.0016	CcSEcCtD
Cevimeline—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.0008	0.0016	CcSEcCtD
Cevimeline—Weight increased—Esomeprazole—Barrett's esophagus	0.000798	0.00159	CcSEcCtD
Cevimeline—Weight increased—Omeprazole—Barrett's esophagus	0.000798	0.00159	CcSEcCtD
Cevimeline—Weight decreased—Omeprazole—Barrett's esophagus	0.000793	0.00158	CcSEcCtD
Cevimeline—Weight decreased—Esomeprazole—Barrett's esophagus	0.000793	0.00158	CcSEcCtD
Cevimeline—Depression—Esomeprazole—Barrett's esophagus	0.00078	0.00156	CcSEcCtD
Cevimeline—Depression—Omeprazole—Barrett's esophagus	0.00078	0.00156	CcSEcCtD
Cevimeline—Stomatitis—Esomeprazole—Barrett's esophagus	0.000762	0.00152	CcSEcCtD
Cevimeline—Stomatitis—Omeprazole—Barrett's esophagus	0.000762	0.00152	CcSEcCtD
Cevimeline—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00076	0.00152	CcSEcCtD
Cevimeline—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00076	0.00152	CcSEcCtD
Cevimeline—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00076	0.00152	CcSEcCtD
Cevimeline—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00076	0.00152	CcSEcCtD
Cevimeline—Haematuria—Esomeprazole—Barrett's esophagus	0.000746	0.00149	CcSEcCtD
Cevimeline—Haematuria—Omeprazole—Barrett's esophagus	0.000746	0.00149	CcSEcCtD
Cevimeline—Epistaxis—Omeprazole—Barrett's esophagus	0.000738	0.00147	CcSEcCtD
Cevimeline—Epistaxis—Esomeprazole—Barrett's esophagus	0.000738	0.00147	CcSEcCtD
Cevimeline—Sinusitis—Esomeprazole—Barrett's esophagus	0.000734	0.00146	CcSEcCtD
Cevimeline—Sinusitis—Omeprazole—Barrett's esophagus	0.000734	0.00146	CcSEcCtD
Cevimeline—Agranulocytosis—Omeprazole—Barrett's esophagus	0.00073	0.00146	CcSEcCtD
Cevimeline—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.00073	0.00146	CcSEcCtD
Cevimeline—Rhinitis—Esomeprazole—Barrett's esophagus	0.000704	0.00141	CcSEcCtD
Cevimeline—Rhinitis—Omeprazole—Barrett's esophagus	0.000704	0.00141	CcSEcCtD
Cevimeline—Hallucination—Esomeprazole—Barrett's esophagus	0.000698	0.00139	CcSEcCtD
Cevimeline—Hallucination—Omeprazole—Barrett's esophagus	0.000698	0.00139	CcSEcCtD
Cevimeline—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000698	0.00139	CcSEcCtD
Cevimeline—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000698	0.00139	CcSEcCtD
Cevimeline—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000697	0.00139	CcSEcCtD
Cevimeline—Pharyngitis—Omeprazole—Barrett's esophagus	0.000697	0.00139	CcSEcCtD
Cevimeline—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000691	0.00138	CcSEcCtD
Cevimeline—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000691	0.00138	CcSEcCtD
Cevimeline—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000688	0.00137	CcSEcCtD
Cevimeline—Urethral disorder—Omeprazole—Barrett's esophagus	0.000688	0.00137	CcSEcCtD
Cevimeline—Visual impairment—Esomeprazole—Barrett's esophagus	0.000676	0.00135	CcSEcCtD
Cevimeline—Visual impairment—Omeprazole—Barrett's esophagus	0.000676	0.00135	CcSEcCtD
Cevimeline—Eye disorder—Esomeprazole—Barrett's esophagus	0.000656	0.00131	CcSEcCtD
Cevimeline—Eye disorder—Omeprazole—Barrett's esophagus	0.000656	0.00131	CcSEcCtD
Cevimeline—Tinnitus—Omeprazole—Barrett's esophagus	0.000654	0.00131	CcSEcCtD
Cevimeline—Tinnitus—Esomeprazole—Barrett's esophagus	0.000654	0.00131	CcSEcCtD
Cevimeline—Flushing—Omeprazole—Barrett's esophagus	0.000651	0.0013	CcSEcCtD
Cevimeline—Flushing—Esomeprazole—Barrett's esophagus	0.000651	0.0013	CcSEcCtD
Cevimeline—Chills—Esomeprazole—Barrett's esophagus	0.00063	0.00126	CcSEcCtD
Cevimeline—Chills—Omeprazole—Barrett's esophagus	0.00063	0.00126	CcSEcCtD
Cevimeline—Alopecia—Omeprazole—Barrett's esophagus	0.00062	0.00124	CcSEcCtD
Cevimeline—Alopecia—Esomeprazole—Barrett's esophagus	0.00062	0.00124	CcSEcCtD
Cevimeline—Malnutrition—Esomeprazole—Barrett's esophagus	0.000611	0.00122	CcSEcCtD
Cevimeline—Malnutrition—Omeprazole—Barrett's esophagus	0.000611	0.00122	CcSEcCtD
Cevimeline—Flatulence—Esomeprazole—Barrett's esophagus	0.000602	0.0012	CcSEcCtD
Cevimeline—Flatulence—Omeprazole—Barrett's esophagus	0.000602	0.0012	CcSEcCtD
Cevimeline—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000598	0.00119	CcSEcCtD
Cevimeline—Dysgeusia—Omeprazole—Barrett's esophagus	0.000598	0.00119	CcSEcCtD
Cevimeline—Back pain—Esomeprazole—Barrett's esophagus	0.000591	0.00118	CcSEcCtD
Cevimeline—Back pain—Omeprazole—Barrett's esophagus	0.000591	0.00118	CcSEcCtD
Cevimeline—Muscle spasms—Omeprazole—Barrett's esophagus	0.000587	0.00117	CcSEcCtD
Cevimeline—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000587	0.00117	CcSEcCtD
Cevimeline—Tremor—Esomeprazole—Barrett's esophagus	0.000572	0.00114	CcSEcCtD
Cevimeline—Tremor—Omeprazole—Barrett's esophagus	0.000572	0.00114	CcSEcCtD
Cevimeline—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000567	0.00113	CcSEcCtD
Cevimeline—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000567	0.00113	CcSEcCtD
Cevimeline—Anaemia—Esomeprazole—Barrett's esophagus	0.000565	0.00113	CcSEcCtD
Cevimeline—Anaemia—Omeprazole—Barrett's esophagus	0.000565	0.00113	CcSEcCtD
Cevimeline—Agitation—Omeprazole—Barrett's esophagus	0.000562	0.00112	CcSEcCtD
Cevimeline—Agitation—Esomeprazole—Barrett's esophagus	0.000562	0.00112	CcSEcCtD
Cevimeline—Malaise—Omeprazole—Barrett's esophagus	0.000551	0.0011	CcSEcCtD
Cevimeline—Malaise—Esomeprazole—Barrett's esophagus	0.000551	0.0011	CcSEcCtD
Cevimeline—Vertigo—Omeprazole—Barrett's esophagus	0.000549	0.0011	CcSEcCtD
Cevimeline—Vertigo—Esomeprazole—Barrett's esophagus	0.000549	0.0011	CcSEcCtD
Cevimeline—Leukopenia—Omeprazole—Barrett's esophagus	0.000547	0.00109	CcSEcCtD
Cevimeline—Leukopenia—Esomeprazole—Barrett's esophagus	0.000547	0.00109	CcSEcCtD
Cevimeline—Palpitations—Omeprazole—Barrett's esophagus	0.00054	0.00108	CcSEcCtD
Cevimeline—Palpitations—Esomeprazole—Barrett's esophagus	0.00054	0.00108	CcSEcCtD
Cevimeline—Cough—Esomeprazole—Barrett's esophagus	0.000533	0.00106	CcSEcCtD
Cevimeline—Cough—Omeprazole—Barrett's esophagus	0.000533	0.00106	CcSEcCtD
Cevimeline—Hypertension—Omeprazole—Barrett's esophagus	0.000528	0.00105	CcSEcCtD
Cevimeline—Hypertension—Esomeprazole—Barrett's esophagus	0.000528	0.00105	CcSEcCtD
Cevimeline—Chest pain—Esomeprazole—Barrett's esophagus	0.00052	0.00104	CcSEcCtD
Cevimeline—Arthralgia—Omeprazole—Barrett's esophagus	0.00052	0.00104	CcSEcCtD
Cevimeline—Myalgia—Esomeprazole—Barrett's esophagus	0.00052	0.00104	CcSEcCtD
Cevimeline—Chest pain—Omeprazole—Barrett's esophagus	0.00052	0.00104	CcSEcCtD
Cevimeline—Myalgia—Omeprazole—Barrett's esophagus	0.00052	0.00104	CcSEcCtD
Cevimeline—Arthralgia—Esomeprazole—Barrett's esophagus	0.00052	0.00104	CcSEcCtD
Cevimeline—Anxiety—Esomeprazole—Barrett's esophagus	0.000518	0.00104	CcSEcCtD
Cevimeline—Anxiety—Omeprazole—Barrett's esophagus	0.000518	0.00104	CcSEcCtD
Cevimeline—Discomfort—Omeprazole—Barrett's esophagus	0.000514	0.00103	CcSEcCtD
Cevimeline—Discomfort—Esomeprazole—Barrett's esophagus	0.000514	0.00103	CcSEcCtD
Cevimeline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000511	0.0173	CbGpPWpGaD
Cevimeline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000511	0.0173	CbGpPWpGaD
Cevimeline—Confusional state—Omeprazole—Barrett's esophagus	0.000503	0.001	CcSEcCtD
Cevimeline—Confusional state—Esomeprazole—Barrett's esophagus	0.000503	0.001	CcSEcCtD
Cevimeline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000496	0.0168	CbGpPWpGaD
Cevimeline—Infection—Omeprazole—Barrett's esophagus	0.000495	0.000989	CcSEcCtD
Cevimeline—Infection—Esomeprazole—Barrett's esophagus	0.000495	0.000989	CcSEcCtD
Cevimeline—Shock—Esomeprazole—Barrett's esophagus	0.000491	0.00098	CcSEcCtD
Cevimeline—Shock—Omeprazole—Barrett's esophagus	0.000491	0.00098	CcSEcCtD
Cevimeline—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00049	0.0166	CbGpPWpGaD
Cevimeline—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000489	0.000977	CcSEcCtD
Cevimeline—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000489	0.000977	CcSEcCtD
Cevimeline—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000488	0.000975	CcSEcCtD
Cevimeline—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000488	0.000975	CcSEcCtD
Cevimeline—Tachycardia—Omeprazole—Barrett's esophagus	0.000487	0.000972	CcSEcCtD
Cevimeline—Tachycardia—Esomeprazole—Barrett's esophagus	0.000487	0.000972	CcSEcCtD
Cevimeline—Skin disorder—Omeprazole—Barrett's esophagus	0.000484	0.000967	CcSEcCtD
Cevimeline—Skin disorder—Esomeprazole—Barrett's esophagus	0.000484	0.000967	CcSEcCtD
Cevimeline—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000482	0.000963	CcSEcCtD
Cevimeline—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000482	0.000963	CcSEcCtD
Cevimeline—Anorexia—Esomeprazole—Barrett's esophagus	0.000475	0.000949	CcSEcCtD
Cevimeline—Anorexia—Omeprazole—Barrett's esophagus	0.000475	0.000949	CcSEcCtD
Cevimeline—CHRM1—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000456	0.0155	CbGpPWpGaD
Cevimeline—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000454	0.000907	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000454	0.000907	CcSEcCtD
Cevimeline—Insomnia—Esomeprazole—Barrett's esophagus	0.000451	0.000901	CcSEcCtD
Cevimeline—Insomnia—Omeprazole—Barrett's esophagus	0.000451	0.000901	CcSEcCtD
Cevimeline—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000448	0.000894	CcSEcCtD
Cevimeline—Paraesthesia—Omeprazole—Barrett's esophagus	0.000448	0.000894	CcSEcCtD
Cevimeline—Dyspnoea—Omeprazole—Barrett's esophagus	0.000445	0.000888	CcSEcCtD
Cevimeline—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000445	0.000888	CcSEcCtD
Cevimeline—Somnolence—Omeprazole—Barrett's esophagus	0.000443	0.000885	CcSEcCtD
Cevimeline—Somnolence—Esomeprazole—Barrett's esophagus	0.000443	0.000885	CcSEcCtD
Cevimeline—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000439	0.000877	CcSEcCtD
Cevimeline—Dyspepsia—Omeprazole—Barrett's esophagus	0.000439	0.000877	CcSEcCtD
Cevimeline—Decreased appetite—Omeprazole—Barrett's esophagus	0.000434	0.000866	CcSEcCtD
Cevimeline—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000434	0.000866	CcSEcCtD
Cevimeline—Fatigue—Omeprazole—Barrett's esophagus	0.00043	0.000859	CcSEcCtD
Cevimeline—Fatigue—Esomeprazole—Barrett's esophagus	0.00043	0.000859	CcSEcCtD
Cevimeline—Pain—Omeprazole—Barrett's esophagus	0.000426	0.000852	CcSEcCtD
Cevimeline—Constipation—Esomeprazole—Barrett's esophagus	0.000426	0.000852	CcSEcCtD
Cevimeline—Constipation—Omeprazole—Barrett's esophagus	0.000426	0.000852	CcSEcCtD
Cevimeline—Pain—Esomeprazole—Barrett's esophagus	0.000426	0.000852	CcSEcCtD
Cevimeline—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000411	0.000821	CcSEcCtD
Cevimeline—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000411	0.000821	CcSEcCtD
Cevimeline—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000408	0.000814	CcSEcCtD
Cevimeline—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000408	0.000814	CcSEcCtD
Cevimeline—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000402	0.0136	CbGpPWpGaD
Cevimeline—Urticaria—Omeprazole—Barrett's esophagus	0.000396	0.000791	CcSEcCtD
Cevimeline—Urticaria—Esomeprazole—Barrett's esophagus	0.000396	0.000791	CcSEcCtD
Cevimeline—Abdominal pain—Omeprazole—Barrett's esophagus	0.000394	0.000787	CcSEcCtD
Cevimeline—Body temperature increased—Omeprazole—Barrett's esophagus	0.000394	0.000787	CcSEcCtD
Cevimeline—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000394	0.000787	CcSEcCtD
Cevimeline—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000394	0.000787	CcSEcCtD
Cevimeline—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000367	0.000734	CcSEcCtD
Cevimeline—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000367	0.000734	CcSEcCtD
Cevimeline—Asthenia—Esomeprazole—Barrett's esophagus	0.000358	0.000714	CcSEcCtD
Cevimeline—Asthenia—Omeprazole—Barrett's esophagus	0.000358	0.000714	CcSEcCtD
Cevimeline—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000354	0.012	CbGpPWpGaD
Cevimeline—Pruritus—Esomeprazole—Barrett's esophagus	0.000353	0.000705	CcSEcCtD
Cevimeline—Pruritus—Omeprazole—Barrett's esophagus	0.000353	0.000705	CcSEcCtD
Cevimeline—Diarrhoea—Omeprazole—Barrett's esophagus	0.000341	0.000681	CcSEcCtD
Cevimeline—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000341	0.000681	CcSEcCtD
Cevimeline—Dizziness—Omeprazole—Barrett's esophagus	0.00033	0.000658	CcSEcCtD
Cevimeline—Dizziness—Esomeprazole—Barrett's esophagus	0.00033	0.000658	CcSEcCtD
Cevimeline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000324	0.011	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—PTGES—Barrett's esophagus	0.000324	0.011	CbGpPWpGaD
Cevimeline—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00032	0.0109	CbGpPWpGaD
Cevimeline—Vomiting—Omeprazole—Barrett's esophagus	0.000317	0.000633	CcSEcCtD
Cevimeline—Vomiting—Esomeprazole—Barrett's esophagus	0.000317	0.000633	CcSEcCtD
Cevimeline—CHRM1—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000315	0.0107	CbGpPWpGaD
Cevimeline—Rash—Omeprazole—Barrett's esophagus	0.000314	0.000628	CcSEcCtD
Cevimeline—Rash—Esomeprazole—Barrett's esophagus	0.000314	0.000628	CcSEcCtD
Cevimeline—CHRM3—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000314	0.0107	CbGpPWpGaD
Cevimeline—Dermatitis—Omeprazole—Barrett's esophagus	0.000314	0.000627	CcSEcCtD
Cevimeline—Dermatitis—Esomeprazole—Barrett's esophagus	0.000314	0.000627	CcSEcCtD
Cevimeline—Headache—Esomeprazole—Barrett's esophagus	0.000312	0.000624	CcSEcCtD
Cevimeline—Headache—Omeprazole—Barrett's esophagus	0.000312	0.000624	CcSEcCtD
Cevimeline—Nausea—Esomeprazole—Barrett's esophagus	0.000296	0.000591	CcSEcCtD
Cevimeline—Nausea—Omeprazole—Barrett's esophagus	0.000296	0.000591	CcSEcCtD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.00029	0.00983	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000289	0.0098	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000282	0.00957	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000281	0.00953	CbGpPWpGaD
Cevimeline—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000263	0.00892	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CYP26A1—Barrett's esophagus	0.000246	0.00833	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000214	0.00725	CbGpPWpGaD
Cevimeline—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000211	0.00715	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—SLC9A1—Barrett's esophagus	0.000177	0.00601	CbGpPWpGaD
Cevimeline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000168	0.0057	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000143	0.00485	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000143	0.00484	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.00014	0.00474	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000138	0.00467	CbGpPWpGaD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000137	0.00465	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000137	0.00464	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—SST—Barrett's esophagus	0.000109	0.0037	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—SST—Barrett's esophagus	0.000109	0.00368	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000104	0.00353	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—GAST—Barrett's esophagus	8.98e-05	0.00305	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—GAST—Barrett's esophagus	8.95e-05	0.00304	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—GAST—Barrett's esophagus	8.16e-05	0.00277	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—GAST—Barrett's esophagus	8.13e-05	0.00276	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—PPARG—Barrett's esophagus	8.08e-05	0.00274	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGES—Barrett's esophagus	8.06e-05	0.00274	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—PTGS2—Barrett's esophagus	6.36e-05	0.00216	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—SST—Barrett's esophagus	6.16e-05	0.00209	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—SST—Barrett's esophagus	6.14e-05	0.00208	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP26A1—Barrett's esophagus	6.11e-05	0.00207	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—SST—Barrett's esophagus	5.59e-05	0.0019	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.57e-05	0.00189	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—SST—Barrett's esophagus	5.57e-05	0.00189	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.56e-05	0.00189	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—TP53—Barrett's esophagus	4.87e-05	0.00165	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGES—Barrett's esophagus	4.82e-05	0.00164	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GAST—Barrett's esophagus	4.82e-05	0.00164	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GAST—Barrett's esophagus	4.8e-05	0.00163	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—SLC9A1—Barrett's esophagus	4.4e-05	0.00149	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CXCL8—Barrett's esophagus	4.24e-05	0.00144	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CXCL8—Barrett's esophagus	4.23e-05	0.00144	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	3.65e-05	0.00124	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SST—Barrett's esophagus	3.3e-05	0.00112	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SST—Barrett's esophagus	3.29e-05	0.00112	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGES—Barrett's esophagus	3.15e-05	0.00107	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	2.63e-05	0.000894	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.4e-05	0.000814	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.39e-05	0.000811	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.39e-05	0.00081	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CXCL8—Barrett's esophagus	2.18e-05	0.000739	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CXCL8—Barrett's esophagus	2.17e-05	0.000737	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARG—Barrett's esophagus	2.01e-05	0.000682	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APC—Barrett's esophagus	1.75e-05	0.000593	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APC—Barrett's esophagus	1.74e-05	0.000591	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.72e-05	0.000584	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS2—Barrett's esophagus	1.58e-05	0.000537	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RELA—Barrett's esophagus	1.37e-05	0.000463	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RELA—Barrett's esophagus	1.36e-05	0.000462	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCL8—Barrett's esophagus	1.29e-05	0.000437	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCL8—Barrett's esophagus	1.28e-05	0.000435	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARG—Barrett's esophagus	1.2e-05	0.000408	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	9.46e-06	0.000321	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TP53—Barrett's esophagus	7.9e-06	0.000268	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TP53—Barrett's esophagus	7.87e-06	0.000267	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARG—Barrett's esophagus	7.86e-06	0.000267	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	6.18e-06	0.00021	CbGpPWpGaD
